Borre, C. I., Poleksic, M., Spears, G., Yi, D., Yang, X., Ali, H., Shukla, B. H., Fitzgerald, J., Khan, M. A., Pradeep, A., Sen, M., Morlote, D., Saha, A., Harada, S., Bennani, N. N., Bailey, L., Koster, M. J., Wade, B., Vassallo, R., Ravindran, A., Moustafa, M. A., Young, J., Valinotti, J. S., Medina, A. A., Shah, M., Tobin, W., Sokolowski, D., Gruber, L., Chang, L., Dasari, S., Hilal, T., Rech, K., Witzig, T., Ahmed, A., Sato, A., Goyal, G., Go, R., Cao, X., Abeykoon, J. (2025). Efficacy of frontline fixed duration chemotherapy in MAPK-pathway altered adult langerhans cell histiocytosis: A multi-institutional international retrospective study. Blood. https://doi.org/10.1182/blood-2025-2999